| Identification | Back Directory | [Name]
preprovasoactive intestinal peptide (111-122) | [CAS]
123025-94-5 | [Synonyms]
L-Valine, L-valyl-L-seryl-L-seryl-L-asparaginyl-L-isoleucyl-L-seryl-L-α-glutamyl-L-α-aspartyl-L-prolyl-L-valyl-L-prolyl- | [Molecular Formula]
C53H87N13O21 | [MDL Number]
MFCD00076540 | [MOL File]
123025-94-5.mol | [Molecular Weight]
1242.33 |
| Chemical Properties | Back Directory | [Boiling point ]
1700.7±65.0 °C(Predicted) | [density ]
1.362±0.06 g/cm3(Predicted) | [pka]
3.70±0.10(Predicted) | [Sequence]
Val-Ser-Ser-Asn-Ile-Ser-Glu-Asp-Pro-Val-Pro-Val |
| Hazard Information | Back Directory | [Uses]
Prepro VIP (111-122), human is a prepro-vasoactive intestinal polypeptide (VIP)-derived peptide, corresponding to residues 111-122. VIP is present in the peripheral and the central nervous systems where it functions as a nonadrenergic, noncholinergic neurotransmitter or neuromodulator[1][2]. | [References]
[1] Bredkjaer HE, et al. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization. Cell Tissue Res. 1994 May;276(2):229-38. DOI:10.1007/BF00306108
[2] Henning RJ, et al. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res. 2001 Jan;49(1):27-37. DOI:10.1016/s0008-6363(00)00229-7 |
|
|